Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stratified Sampling Method01:16

Stratified Sampling Method

12.4K
Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a stratified sample, divide the population into groups called strata and then take a...
12.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

160
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of Melanoma.

MDM policy & practice·2026
Same author

Usage and Exposure to Content of the NHS Healthy Living Program for People With Type 2 Diabetes: Retrospective Observational Cohort Study.

Journal of medical Internet research·2026
Same author

Risk-reducing surgery, risk-reducing medication, and surveillance in young <i>BRCA</i> carriers with breast cancer: considering all the options.

Translational cancer research·2026
Same author

Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer.

BMJ open·2026
Same author

Deep learning models to predict mammographic density jointly on standard dose and low dose images.

The British journal of radiology·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Aug 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting.

Lorna McWilliams1,2, D Gareth Evans2,3,4,5, Katherine Payne2,6

  • 1Manchester Centre for Health Psychology, Division of Psychology & Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Road, Manchester M13 9PL, UK.

Cancers
|October 14, 2022
PubMed
Summary
This summary is machine-generated.

Implementing risk-stratified breast screening in the NHS Breast Screening Programme (NHSBSP) is feasible and desirable. Experts identified key issues for integrating this personalized approach into current services.

Keywords:
breast cancercost-effectivenessepidemiologyhealth inequalitiesmammographyrisk stratificationscreening

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Aug 25, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Oncology
  • Public Health
  • Health Services Research

Background:

  • The National Health Service Breast Screening Programme (NHSBSP) currently screens most women every three years, irrespective of individual breast cancer risk.
  • Advances allow for accurate breast cancer risk assessment, risk-based feedback, and tailored management strategies, including enhanced screening and preventative medication for high-risk individuals.

Framework:

  • A 2022 meeting convened 58 experts to discuss the feasibility and desirability of implementing risk-stratified screening within the NHSBSP.
  • Discussions were informed by findings from the PROCAS2 NIHR programme grant on the practicalities of risk-stratified screening.
  • Thematic analysis of expert discussions identified five key themes: risk/economic modeling, health inequalities/communication, screening interval adjustments, integration with existing services, and new service models.

Implementation:

  • Participants generally anticipated the future implementation of risk-stratified breast screening in England.
  • Key challenges and uncertainties were identified across the five discussed themes, requiring resolution for successful integration.
  • The meeting aimed to set an agenda for addressing these challenges and facilitating the adoption of risk-stratified screening.

Implications:

  • Successful implementation could lead to more personalized and potentially more effective breast cancer screening strategies.
  • Addressing health inequalities and communication is crucial for equitable delivery of risk-stratified services.
  • Further research and policy development are needed to resolve identified issues and optimize new service models for risk-stratified breast screening.